Leading experts from around the U.S. will share their research on pancreatic cancer at a symposium on Monday, July 8 at the Harry D. McGovern Alumni Center at North Dakota State University, 1241 N. University Drive from 9 a.m. to 8 p.m.
Graduate students and faculty from the region will provide poster presentations regarding their pancreatic cancer research.
Invited event guest speakers include:
- Gloria Petersen, Ph.D., Professor of Epidemiology, Mayo Clinic, Director - Pancreatic Cancer Specialized Programs of Research Excellence, National Institutes of Health
- Igor Roninson, Ph.D., Professor, Department of Drug Discovery and Biomedical Sciences, SmartState Chair, University of South Carolina, Director – Center for Targeted Therapeutics
- Luke Theogarajan, Ph.D., Professor, Vice Chair, Department of Electrical and Chemical Engineering, University of California Santa Barbara, Biomimetic Circuits and Nanosystems
- Sudipta Seal, Ph.D., Pegasus Professor and Chair, Department of Materials Science and Engineering, University of Central Florida
- Tatiana Bronich, Ph.D., Parke-Davis Professor, Department of Pharmaceutical Sciences University of Nebraska Medical Center, Co-Director, Center for Drug Delivery and Nanomedicine
- Sushanta Banerjee, Ph.D., Professor, Hematology and Oncology, University of Kansas Medical Center, Research Director – Cancer Research Unit, VA Medical Center, Kansas City
- Raghu Kalluri, M.D., Ph.D., Professor and Chairman, Department of Cancer, Biology, University of Texas MD Anderson Cancer Center
- Michael A. Hollingsworth, Ph.D., Professor at the Eppley Institute for Research in Cancer and Allied Diseases at the University of Nebraska Medical Center, Director - Pancreatic Cancer Specialized Programs of Research Excellence, National Institutes of Health
For program details, visit https://www.ndsu.edu/centers/pancreaticcancer/symposium/
The symposium is coordinated by the Center for Diagnostic and Therapeutic Strategies in Pancreatic Cancer at NDSU. The Center was established with support from the National Institute of General Medical Sciences, under the Center of Biomedical Research Excellence (COBRE) program of the National Institutes of Health, grant 1P20GM109024.
Sanku Mallik, professor of pharmaceutical sciences, and D.K. Srivastava, a James A. Meier Professor of chemistry and biochemistry, lead the Center for Diagnostic and Therapeutic Strategies in Pancreatic Cancer. A competitive grant of up to $9.62 million from NIH funds the first disease specific research center at NDSU.
Life expectancy after a pancreatic cancer diagnosis can be six months or less, Mallik said. A lack of early symptoms, short survival time and resistance to therapy are hallmarks of this deadly disease. The NDSU Center’s research is aimed at early diagnosis and treatment of pancreatic cancer.